Deadline: 30-Sep-26
The Encephalitis International Seed Funding Programme provides grants of up to £10,000 to support pilot encephalitis research projects based in Africa. The programme helps early-career researchers generate preliminary evidence, develop innovative research ideas, and build foundations for future large-scale research funding.
The funding supports research areas including encephalitis epidemiology, diagnosis, treatment access, patient outcomes, vaccination, caregiver support, neuro-rehabilitation, and health system improvement. All funded projects must include patient engagement and consultation.
About the Encephalitis International Seed Funding Programme
The Encephalitis International Seed Funding Programme supports early-stage and pilot research focused on improving understanding, prevention, diagnosis, treatment, and long-term outcomes of encephalitis.
Encephalitis is an inflammation of the brain that can result from infections, immune system disorders, or other causes. The condition can lead to significant health challenges, including neurological disability, cognitive impacts, and long-term care needs.
The programme is designed to support researchers in Africa who need initial funding to test ideas, collect early data, and strengthen applications for future research grants.
Objectives of the Programme
The Seed Funding Programme aims to:
- Support innovative encephalitis research in Africa.
- Generate preliminary evidence for larger research studies.
- Strengthen research capacity among early-career scientists.
- Improve understanding of encephalitis diagnosis and treatment challenges.
- Encourage patient-centred research approaches.
- Promote collaborations between researchers and healthcare professionals.
Research Areas Supported
Applications are encouraged from projects addressing important encephalitis-related challenges, including:
Epidemiology and Disease Surveillance
Research may focus on:
- Understanding encephalitis burden in African communities.
- Improving disease monitoring systems.
- Identifying risk factors and patterns of infection.
Diagnostics and Treatment Access
Projects may explore:
- Improved diagnostic approaches.
- Barriers to timely diagnosis.
- Access to effective treatment.
- Healthcare system improvements.
Mortality and Long-Term Outcomes
Research may investigate:
- Factors influencing survival.
- Long-term neurological outcomes.
- Disability and quality-of-life impacts after encephalitis.
Vaccination and Prevention
Projects may include:
- Vaccine-related research.
- Vaccine awareness.
- Vaccine hesitancy.
- Prevention strategies.
Caregiver Support and Economic Impact
Studies may examine:
- The experiences of caregivers.
- Social and economic impacts of encephalitis.
- Support systems for affected families.
Neurology Training and Neuro-Rehabilitation
Research may focus on:
- Building neurological care capacity.
- Training healthcare professionals.
- Rehabilitation approaches for survivors.
Funding Details
Successful applicants can receive:
- Maximum grant amount: Up to £10,000
- Project duration: 12 to 18 months
- Possible extension: Up to 6 months only in exceptional circumstances
The grant is intended for new pilot research projects that can lead to future research opportunities.
Eligible Use of Funding
The grant can support eligible research costs required to deliver the project.
However, funding cannot be used for:
- Hardware purchases.
- Equipment costs.
- Institutional overheads.
- Existing research projects.
- Bridge funding.
- Standalone projects without plans for future development.
Travel costs must:
- Be clearly justified.
- Not exceed 33% of the total grant budget.
Who Is Eligible?
The programme is open to researchers conducting encephalitis research in Africa.
Eligible applicants include:
- Medical students.
- Junior doctors.
- Early-career researchers.
- Postdoctoral researchers.
- Researchers returning to research careers.
- Individuals with equivalent professional research experience.
Priority is given to applicants who are at an early stage of their academic or research career.
Applicants must:
- Be affiliated with a recognised academic institution.
- Conduct the research project in Africa.
- Submit two letters of support from supervisors or institutional leaders.
Research Location Requirements
Projects must:
- Be based in Africa.
- Represent new research activity in the location where the study takes place.
Collaborations are encouraged, including:
- Partnerships within the same country.
- Cross-border collaborations.
- Regional research partnerships.
Why This Funding Matters
Encephalitis remains a significant global health challenge, particularly in regions where diagnosis, treatment, neurological care, and rehabilitation services may be limited.
This funding helps researchers:
- Develop evidence-based solutions.
- Address local healthcare challenges.
- Improve patient outcomes.
- Build sustainable research capacity.
- Strengthen future grant applications.
By supporting early-stage research, the programme contributes to better understanding and management of encephalitis across Africa.
How to Apply
Applicants should follow these steps:
Step 1: Develop a Research Idea
Prepare a pilot research proposal addressing an important encephalitis-related challenge.
The project should clearly explain:
- The research question.
- The importance of the study.
- Expected outcomes.
- Future research potential.
Step 2: Confirm Eligibility
Applicants should confirm that they:
- Are affiliated with a recognised academic institution.
- Are conducting research in Africa.
- Meet the career-stage requirements.
Step 3: Prepare Supporting Documents
Applications must include:
- Research proposal.
- Project budget.
- Two letters of support from supervisors or institutional heads.
- Required institutional information.
Step 4: Submit the Application
Applicants should submit the completed application according to the official programme requirements.
Reporting and Responsibilities After Funding
Successful applicants must complete reporting requirements after the project ends.
Awardees must:
- Submit a final report within three months of project completion.
- Explain how funding was used.
- Describe research outcomes.
- Provide future research plans.
Awardees are also expected to:
- Share updates on future funding applications.
- Report publications resulting from the project.
- Provide career progress updates.
- Present findings at the annual Encephalitis Conference.
- Acknowledge Encephalitis International in publications and communications.
- Make publications open access where possible.
- Consider involving Encephalitis International in future grant applications.
Projects Not Eligible for Funding
The programme does not support:
- Existing research projects.
- Projects without future development potential.
- Bridge funding.
- Animal research conducted outside the UK.
- Projects requiring major equipment purchases.
Tips for a Strong Application
Applicants should:
- Clearly define the research problem.
- Demonstrate relevance to African healthcare needs.
- Explain how the pilot study can lead to larger research.
- Include meaningful patient engagement.
- Provide a realistic budget.
- Highlight collaboration opportunities.
- Explain the expected impact on encephalitis care.
Common Mistakes to Avoid
Applicants should avoid:
- Proposing research without patient involvement.
- Requesting funding for equipment or overhead costs.
- Submitting projects that are already underway.
- Failing to explain future research plans.
- Exceeding the travel budget limit.
- Providing incomplete institutional support documents.
Frequently Asked Questions (FAQs)
What is the Encephalitis International Seed Funding Programme?
It is a research grant programme supporting early-stage encephalitis studies in Africa by providing pilot funding for innovative projects.
How much funding can researchers receive?
Researchers can apply for grants of up to £10,000 for projects lasting 12 to 18 months.
Who can apply for the grant?
Eligible applicants include early-career researchers, medical students, junior doctors, postdoctoral researchers, and researchers returning to research who are affiliated with recognised academic institutions.
Must the research project be based in Africa?
Yes. Projects must be based in Africa, and the research should be new to the location where it is being conducted.
Can funding be used to buy equipment?
No. Hardware, equipment purchases, and institutional overhead costs are not eligible.
Are collaborations allowed?
Yes. Applications may involve collaborations within the same country or between neighbouring countries and regions.
What happens after receiving funding?
Awardees must submit a final report, share research outcomes, acknowledge Encephalitis International, and provide updates on publications and future funding activities.
Conclusion
The Encephalitis International Seed Funding Programme provides essential support for early-stage encephalitis research in Africa by funding innovative pilot studies and strengthening research capacity. With grants of up to £10,000, the programme enables researchers to generate evidence, improve patient-focused solutions, and build pathways toward larger research initiatives that can improve encephalitis prevention, diagnosis, treatment, and long-term care.
For more information, visit Encephalitis International.
